Palisade Bio (PALI) EPS (Basic) Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,207.14% |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | 89.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.36% |
| Dec 31, 2025 | 256.52% |
| Sep 30, 2025 | 83.62% |
| Jun 30, 2025 | 82.53% |
| Mar 31, 2025 | 89.76% |
| Dec 31, 2024 | 81.70% |
| Sep 30, 2024 | 68.56% |
| Jun 30, 2024 | 58.13% |
| Mar 31, 2024 | 43.54% |
| Dec 31, 2023 | -301.60% |
| Sep 30, 2023 | -80.00% |
| Jun 30, 2023 | -37.44% |
| Mar 31, 2023 | 37.27% |
| Dec 31, 2022 | 101.34% |
| Sep 30, 2022 | -1,076.19% |
| Jun 30, 2022 | -60.72% |
| Mar 31, 2022 | -1,540.51% |
| Dec 31, 2021 | -9,014.38% |
| Sep 30, 2021 | 163.64% |
| Jun 30, 2021 | -435.82% |
| Mar 31, 2021 | 85.84% |
| Dec 31, 2020 | -253.00% |
| Sep 30, 2020 | -11.86% |
| Jun 30, 2020 | 53.79% |
| Mar 31, 2020 | -63.16% |
| Dec 31, 2019 | 168.49% |
| Sep 30, 2019 | 75.52% |
| Jun 30, 2019 | -74.70% |
| Mar 31, 2019 | -2,342.86% |
| Dec 31, 2018 | -630.00% |
| Sep 30, 2018 | -24,000.00% |
| Jun 30, 2018 | -112.82% |
| Mar 31, 2018 | 79.41% |
| Dec 31, 2017 | 64.91% |
| Sep 30, 2017 | 98.31% |
| Jun 30, 2017 | 17.02% |
| Mar 31, 2017 | 26.88% |
| Dec 31, 2016 | -1,040.00% |
| Sep 30, 2016 | -883.33% |
| Jun 30, 2016 | -683.33% |
| Mar 31, 2016 | -1,450.00% |
| Dec 31, 2015 | 16.67% |
| Sep 30, 2015 | -20.00% |
| Jun 30, 2015 | 25.00% |
| Mar 31, 2015 | 14.29% |
| Dec 31, 2014 | -50.00% |
| Sep 30, 2014 | 44.44% |
| Jun 30, 2014 | 11.11% |
| Mar 31, 2014 | -40.00% |
| Dec 31, 2013 | 0.00% |
| Sep 30, 2013 | -125.00% |
| Jun 30, 2013 | -125.00% |
| Mar 31, 2013 | 0.00% |
| Dec 31, 2012 | 20.00% |
| Sep 30, 2012 | 42.86% |
| Jun 30, 2012 | 50.00% |
| Mar 31, 2012 | 28.57% |
| Dec 31, 2011 | 0.00% |
| Sep 30, 2011 | 22.22% |
| Jun 30, 2011 | 33.33% |